Physician profile
Davina Prida
NPI 1891095659
$461.96
in general payments reported to CMS, 2019-2025
10 companies · $93.71 in 2025
The $93.71 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $78.36 · 2021: $62.27 · 2022: $18.17 · 2023: $31.73 · 2024: $32.42 · 2025: $93.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $246.95 | 2019-2024 | Itero Element 5d, Invisalign |
| Straumann USA LLC | $59.08 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $36.47 | 2022-2025 | Arestin |
| Elevate Oral Care | $24.72 | 2019 | |
| Implant Direct Sybron International LLC | $18.08 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.97 | 2021 | |
| Dmg America LLC | $16.33 | 2025 | |
| Voco America INC. | $15.96 | 2020 | |
| Philips North America LLC | $14.43 | 2024 | (3110) Oral Health Care Und |
| Ultradent Products INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davina Prida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.